Insider filing · ETON
Sean Brynjelsen
President & CEO
profile →
Eton Pharmaceuticals, Inc.
ETON · Healthcare · 14 filings in 24 months
ticker →
Sean Brynjelsen sold $3.6M of Eton Pharmaceuticals (ETON)
Executed Jun 3 2025, disclosed Jun 5 2025, 2 days later.
Value, as filed
$3.6M
209,600 sh across 4 lots
Executed
Jun 3 2025
the trade date, as filed
Disclosed
Jun 5 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBSean Brynjelsen (President & CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Eton Pharmaceuticals, Inc. (ETON). The largest single filing was $6.1M of ETON (100,000 sh across 4 lots, as filed), executed Aug 19.
The name
ETONHealthcare · Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sean Brynjelsen in ETON
ETONSALE
Eton Pharmaceuticals, Inc.
$6.1M100,000 sh across 4 lots
Exec Aug 19
Filed Aug 20 · 6:26 PM ET ETONSALE Eton Pharmaceuticals, Inc. $3.8M
119,852 sh × $31.88
Exec May 28
Filed May 29 · 5:30 PM ET